Our Resources | Association for Accessible Medicines

Access! 2020 - Early-bird special: Save $500 off full-pass registration when you register by Feb 10.

AAM Statement on H3

Dec 13, 2019 | Rachel Schwartz

AAM Statement on HR 3

Dec 12, 2019 | Chip Davis

Letter from AAM: Mr. President, Block the BLOCKING Act!

Dec 11, 2019 | Erica Klinger

Generic Drug Savings in the U.S.

Dec 10, 2019 | Rachel Schwartz

USMCA Trade Agreement: A Victory for America’s Patients

Dec 9, 2019 | Rachel Schwartz

AAM Opposes the Lower Health Care Costs Act

Nov 19, 2019 | Erica Klinger

USMCA: Nothing to See Here (Infographic)

Nov 19, 2019 | Jonathan Kimball

Myths vs. Facts of Biologic Market Exclusivity in Mexico — #FixUSMCA

Nov 18, 2019 | Erica Klinger

Dispensary of Hope: The Industry’s Nonprofit Supply-Chain Partner

Nov 14, 2019 | Erica Klinger

How Our Associate Members Make the World Healthier

GRx+Biosims Day 3 Healthcare Innovation and The Political Economy

Nov 11, 2019 | Erica Klinger

GRx+Biosims Year 2: The Recap

FDA - Nomination of Dr. Stephen Hahn to FDA

Nov 1, 2019 | Rachel Schwartz

AAM Statement on Nomination of Dr. Stephen Hahn to FDA

Generic Rx World Manufacturing

Oct 29, 2019 | Rachel Schwartz

AAM Testimony on the Generic Global Supply Chain—Five Takeaways